$AGLE Aeglea BioTherapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aeglea BioTherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aeglea BioTherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Aeglea BioTherapeutics, Inc. for free.
IRS Number: 464312787
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AGLE
Company Address: 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN 78746
Phone number: (512) 942-2935
Former name: Aeglea BioTherapeutics Holdings, LLC
Market Capitalization: $56.54M
Prev close: $4.19
Average Daily Volume: 50,532
Days Low: $4.10
Year Low: $3.66
Year High: $12.75
Aeglea BioTherapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | AGLE | Aeglea BioTherapeu ... | Souza Marcio | Director | Option Exercise | A | 6.44 | 60,000 | 386,400 | 60,000 | |
| Jun 09 2021 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 6.80 | 40,000 | 272,000 | 40,000 | |
| Jun 09 2021 | AGLE | Aeglea BioTherapeu ... | Magovcevic-Liebisch Ivana | Director | Option Exercise | A | 6.80 | 40,000 | 272,000 | 40,000 | |
| Feb 25 2021 | AGLE | Aeglea BioTherapeu ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 7.11 | 47,200 | 335,592 | 47,200 | |
| Feb 19 2021 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Option Exercise | A | 7.35 | 330,000 | 2,425,500 | 330,000 | |
| Feb 19 2021 | AGLE | Aeglea BioTherapeu ... | Hanley Jr. Michael Conick | Chief Commercial Of ... | Option Exercise | A | 7.35 | 135,000 | 992,250 | 135,000 | |
| Dec 17 2020 | AGLE | Aeglea BioTherapeu ... | Lawton Alison Frances | Director | Option Exercise | A | 9.09 | 47,200 | 429,048 | 47,200 | |
| Jun 10 2020 | AGLE | Aeglea BioTherapeu ... | Shanafelt Armen | Director | Option Exercise | A | 8.89 | 28,100 | 249,809 | 28,100 | |
| Jun 10 2020 | AGLE | Aeglea BioTherapeu ... | Mahatme Sandesh | Director | Option Exercise | A | 8.89 | 28,100 | 249,809 | 28,100 | |
| Jun 10 2020 | AGLE | Aeglea BioTherapeu ... | Magovcevic Ivana | Director | Option Exercise | A | 8.89 | 28,100 | 249,809 | 28,100 | |
| Jun 10 2020 | AGLE | Aeglea BioTherapeu ... | LAWLIS V BRYAN | Director | Option Exercise | A | 8.89 | 28,100 | 249,809 | 28,100 | |
| Jun 10 2020 | AGLE | Aeglea BioTherapeu ... | Cox Russell J. | Director | Option Exercise | A | 8.89 | 28,100 | 249,809 | 28,100 | |
| Jun 10 2020 | AGLE | Aeglea BioTherapeu ... | Bruhn Suzanne Louise | Director | Option Exercise | A | 8.89 | 28,100 | 249,809 | 28,100 | |
| May 04 2020 | AGLE | Aeglea BioTherapeu ... | Quinn Anthony G. | President & CEO | Buy | P | 4.75 | 165,000 | 783,750 | 538,469 | 373.5 K to 538.5 K (+44.18 %) |
| Feb 19 2020 | AGLE | Aeglea BioTherapeu ... | York Charles N II | Chief Financial Off ... | Option Exercise | A | 8.15 | 126,000 | 1,026,900 | 126,000 |